Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug ...

CNW/ - ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-T) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As the Jacksonville Jaguars prepare to face the Miami Dolphins, much will be made about the difficulty of stopping the Dolphins offense. Last season, the Dolphins’ offense ranked as one of the ...

Eupraxia Pharmaceuticals Inc. (EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug delivery for applications with ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug ...

The Company's presentation is at 8:00 a.m. ET on Monday, September 9, 2024 . Eupraxia invites all interested parties to view the presentation by clicking on the following link: A webcast of the ...

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is ...

A webcast of the presentation will also be available on the Events and Presentations page of the Company's website here. About Eupraxia Pharmaceuticals Inc. Eupraxia is a clinical-stage ...